Executive Committee
Under the leadership of Vasant Narasimhan, the Executive Committee of Novartis (ECN) is responsible for overseeing the business operations of Group companies. ECN members are chosen by the Board of Directors.
Vasant (Vas) Narasimhan, M.D.
James (Jay) Bradner, M.D.
James (Jay) Bradner, M.D.
President of Novartis Institutes for BioMedical Research (NIBR)
Karen L. Hale
Harry Kirsch
Steffen Lang, Ph.D.
Klaus Moosmayer, Ph.D.
Richard Saynor
Susanne Schaffert, Ph.D.
John Tsai, M.D.
John Tsai, M.D.
Head of Global Drug Development and Chief Medical Officer for Novartis
Marie-France Tschudin
Robert Weltevreden
Other Members of Senior Management
Other Members of Senior Management
Bertrand Bodson
Lutz Hegemann, M.D., Ph.D.
Vicki Rawlinson
Natacha Theytaz
Natacha Theytaz
Global Head of Novartis Business Assurance & Advisory and Head of Internal Audit
Michael Willi
